Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment

<p>Abstract</p> <p>Background</p> <p>The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment.</p&...

Full description

Bibliographic Details
Main Authors: Kuo Chao-Hung, Lu Chien-Yu, Cheng Su-Chen, Chu Koung-Shing, Sun Li-Chu, Hsieh Jan-Sing, Shih Ying-Ling, Chang Shun-Jen, Wang Jaw-Yuan
Format: Article
Language:English
Published: BMC 2009-08-01
Series:BMC Cancer
Online Access:http://www.biomedcentral.com/1471-2407/9/288
id doaj-a0dceba704bc4a319af3bae92b851815
record_format Article
spelling doaj-a0dceba704bc4a319af3bae92b8518152020-11-24T21:52:51ZengBMCBMC Cancer1471-24072009-08-019128810.1186/1471-2407-9-288Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatmentKuo Chao-HungLu Chien-YuCheng Su-ChenChu Koung-ShingSun Li-ChuHsieh Jan-SingShih Ying-LingChang Shun-JenWang Jaw-Yuan<p>Abstract</p> <p>Background</p> <p>The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment.</p> <p>Methods</p> <p>Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely.</p> <p>Results</p> <p>Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3–132 months). A multivariate analysis identified that low serum albumin level (<it>P </it>= 0.011), advanced UICC stage (<it>P </it>< 0.001), and high carcinoembryonic antigen (CEA) level (<it>P </it>< 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (<it>P </it>< 0.001), advanced UICC stage (<it>P </it>< 0.001), and high CEA level (<it>P </it>< 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories.</p> <p>Conclusion</p> <p>Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment.</p> http://www.biomedcentral.com/1471-2407/9/288
collection DOAJ
language English
format Article
sources DOAJ
author Kuo Chao-Hung
Lu Chien-Yu
Cheng Su-Chen
Chu Koung-Shing
Sun Li-Chu
Hsieh Jan-Sing
Shih Ying-Ling
Chang Shun-Jen
Wang Jaw-Yuan
spellingShingle Kuo Chao-Hung
Lu Chien-Yu
Cheng Su-Chen
Chu Koung-Shing
Sun Li-Chu
Hsieh Jan-Sing
Shih Ying-Ling
Chang Shun-Jen
Wang Jaw-Yuan
Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
BMC Cancer
author_facet Kuo Chao-Hung
Lu Chien-Yu
Cheng Su-Chen
Chu Koung-Shing
Sun Li-Chu
Hsieh Jan-Sing
Shih Ying-Ling
Chang Shun-Jen
Wang Jaw-Yuan
author_sort Kuo Chao-Hung
title Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_short Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_full Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_fullStr Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_full_unstemmed Preoperative serum carcinoembryonic antigen, albumin and age are supplementary to UICC staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
title_sort preoperative serum carcinoembryonic antigen, albumin and age are supplementary to uicc staging systems in predicting survival for colorectal cancer patients undergoing surgical treatment
publisher BMC
series BMC Cancer
issn 1471-2407
publishDate 2009-08-01
description <p>Abstract</p> <p>Background</p> <p>The aim of this study was to determine influence of prognostic factors in addition to UICC staging systems, on cancer-specific and overall survival rates for patients with colorectal cancer (CRC) undergoing surgical treatment.</p> <p>Methods</p> <p>Between January 1996 and December 2006, a total of 1367 CRC patients who underwent surgical treatment in Kaohsiung Medical University Hospital were analyzed. We retrospectively investigated clinicopathologic features of these patients. All patients were followed up intensively, and their outcomes were investigated completely.</p> <p>Results</p> <p>Of 1367 CRC patients, there were seven hundred and fifty-seven males (55.4%) and 610 (44.6%) females. The median follow-up period was 60 months (range, 3–132 months). A multivariate analysis identified that low serum albumin level (<it>P </it>= 0.011), advanced UICC stage (<it>P </it>< 0.001), and high carcinoembryonic antigen (CEA) level (<it>P </it>< 0.001) were independent prognostic factors of cancer-specific survival. Meanwhile, a multivariate analysis showed age over 65 years (<it>P </it>< 0.001), advanced UICC stage (<it>P </it>< 0.001), and high CEA level (<it>P </it>< 0.001) were independent prognostic factors of overall survival. Furthermore, combination of UICC stage, serum CEA and albumin levels as predictors of cancer-specific survival showed that the poorer the prognostic factors involved, the poorer the cancer-specific survival rate. Likewise, combination of UICC stage, age and serum CEA level as predictors of overall survival showed that the poorer the prognostic factors involved, the poorer the overall survival rate. Of these prognostic factors, preoperative serum CEA level was the only significant prognostic factor for patients with stage II and III CRCs in both cancer-specific and overall survival categories.</p> <p>Conclusion</p> <p>Preoperative serum albumin level, CEA level and age could prominently affect postoperative outcome of CRC patients undergoing surgical treatment. In addition to conventional UICC staging system, it might be imperative to take these additional characteristics of factors into account in CRC patients prior to surgical treatment.</p>
url http://www.biomedcentral.com/1471-2407/9/288
work_keys_str_mv AT kuochaohung preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT luchienyu preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT chengsuchen preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT chukoungshing preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT sunlichu preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT hsiehjansing preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT shihyingling preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT changshunjen preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
AT wangjawyuan preoperativeserumcarcinoembryonicantigenalbuminandagearesupplementarytouiccstagingsystemsinpredictingsurvivalforcolorectalcancerpatientsundergoingsurgicaltreatment
_version_ 1725874482410684416